The COVID-19 pandemic dramatically accelerated cancer-vaccine science by validating the mRNA technology at global scale.
Michelle Wang
Advertisement
Michelle Wang is an Analyst at Windrose Consulting Group in Philadelphia.
Articles by Michelle Wang
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on PharmExec
1
FDA Removes Two Study Requirement for New Drug Approval Process: Report
2
BioNTech Files Suit Against Moderna for Patent Infringement
3
The Emergence of Cancer Vaccines: Reframing Value Demonstration, Pricing, and Access
4
How FDA's Action Against Non-FDA-Approved GLP-1 Products Affects the Competitive Landscape
5